Patents by Inventor Kevin Friedman

Kevin Friedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BCMA CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20210052711
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: October 23, 2020
    Publication date: February 25, 2021
    Applicant: bluebird bio, Inc.
    Inventors: Richard MORGAN, Kevin FRIEDMAN
  • BCMA CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20210038705
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: October 23, 2020
    Publication date: February 11, 2021
    Applicant: bluebird bio, Inc.
    Inventors: Richard MORGAN, Kevin FRIEDMAN
  • MND PROMOTER CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20210032658
    Abstract: The invention provides vector compositions for delivering improved adoptive T cell therapies.
    Type: Application
    Filed: August 7, 2020
    Publication date: February 4, 2021
    Applicant: bluebird bio, Inc.
    Inventors: Richard MORGAN, Kevin FRIEDMAN, Byoung RYU
  • BCMA CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20200330572
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: April 1, 2020
    Publication date: October 22, 2020
    Applicant: bluebird bio, Inc.
    Inventors: Richard MORGAN, Kevin FRIEDMAN
  • MND promoter chimeric antigen receptors
    Patent number: 10774343
    Abstract: Vector compositions comprising a myeloproliferative sarcoma virus enhancer, negative control region deleted, dl587rev primer-binding site substituted (MND) promoter operably linked to a chimeric antigen receptor (CAR) are provided.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: September 15, 2020
    Assignee: bluebird bio, Inc.
    Inventors: Richard Morgan, Kevin Friedman, Byoung Ryu
  • BCMA chimeric antigen receptors
    Patent number: 10646558
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: May 12, 2020
    Assignee: bluebird bio, Inc.
    Inventors: Richard Morgan, Kevin Friedman
  • SURGICAL RETENTION FEATURE
    Publication number: 20200138542
    Abstract: A light guide assembly for use with a retractor having a channel for slidably receiving an end portion of a light guide. The light guide assembly includes a light guide having the end portion for slidably inserting into the channel and retentor for releasably holding in position the end portion relative to the retractor.
    Type: Application
    Filed: September 12, 2019
    Publication date: May 7, 2020
    Inventors: Brandon Shafer-Zatko, RJ Hagler, Joe Dombrowski, Kevin Friedman, Vedang Kothari, Brian Andrich, Alan Greszler
  • BCMA chimeric antigen receptors
    Patent number: 10639358
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: May 5, 2020
    Assignee: bluebird bio, Inc.
    Inventors: Richard Morgan, Kevin Friedman
  • BCMA chimeric antigen receptors
    Patent number: 10639359
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: May 5, 2020
    Assignee: bluebird bio, Inc.
    Inventors: Richard Morgan, Kevin Friedman
  • BCMA chimeric antigen receptors
    Patent number: 10624960
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: April 21, 2020
    Assignee: bluebird bio, Inc.
    Inventors: Richard Morgan, Kevin Friedman
  • METHODS OF MAKING T CELL COMPOSITIONS
    Publication number: 20200109365
    Abstract: The invention provides improved T cell compositions and methods for manufacturing T cells. More particularly, the invention provides methods of T cell manufacturing that result in adoptive T cell immunotherapies with improved survival, expansion, and persistence in vivo.
    Type: Application
    Filed: October 9, 2019
    Publication date: April 9, 2020
    Applicant: Bluebird Bio, Inc.
    Inventor: Kevin Friedman
  • BCMA CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20200079864
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: July 18, 2019
    Publication date: March 12, 2020
    Applicant: bluebird bio, Inc.
    Inventors: Richard MORGAN, Kevin Friedman
  • BCMA chimeric antigen receptors
    Patent number: 10576133
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: March 3, 2020
    Assignee: bluebird bio, Inc.
    Inventors: Richard Morgan, Kevin Friedman
  • BCMA chimeric antigen receptors
    Patent number: 10576134
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: March 3, 2020
    Assignee: bluebird bio, Inc.
    Inventors: Richard Morgan, Kevin Friedman
  • BCMA CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20190388526
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: July 3, 2019
    Publication date: December 26, 2019
    Applicant: bluebird bio, Inc.
    Inventors: Richard MORGAN, Kevin FRIEDMAN
  • BCMA CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20190388525
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: July 3, 2019
    Publication date: December 26, 2019
    Applicant: bluebird bio, Inc.
    Inventors: Richard MORGAN, Kevin FRIEDMAN
  • BCMA CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20190388528
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: July 8, 2019
    Publication date: December 26, 2019
    Applicant: bluebird bio, Inc.
    Inventors: Richard MORGAN, Kevin FRIEDMAN
  • BCMA CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20190388527
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: July 8, 2019
    Publication date: December 26, 2019
    Applicant: bluebird bio, Inc.
    Inventors: Richard Morgan, Kevin Friedman
  • Methods of making T cell compositions
    Patent number: 10479975
    Abstract: The invention provides improved T cell compositions and methods for manufacturing T cells. More particularly, the invention provides methods of T cell manufacturing that result in adoptive T cell immunotherapies with improved survival, expansion, and persistence in vivo.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: November 19, 2019
    Assignee: bluebird bio, Inc.
    Inventor: Kevin Friedman
  • BCMA chimeric antigen receptors
    Patent number: 10383929
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: August 20, 2019
    Assignee: bluebird bio, Inc.
    Inventors: Richard Morgan, Kevin Friedman